Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of fasedienol met the primary and secondary endpoints.
TLG Acquisition One Corp. (TLGA) shares are gaining more than 6 percent on Monday morning trade. In a filing with SEC, the company and Electriq Power, Inc. entered into an agreement with Meteora Special Opportunity Fund I, LP, Meteora Capital Partners, LP, and Meteora Select Trading Opportunities Master, LP for an OTC Equity Prepaid Forward Transaction.
Form 8-K Freedom Acquisition I For: Jul 13 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.